236 related articles for article (PubMed ID: 22171261)
1. The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence.
Schweneker M; Lukassen S; Späth M; Wolferstätter M; Babel E; Brinkmann K; Wielert U; Chaplin P; Suter M; Hausmann J
J Virol; 2012 Feb; 86(4):2323-36. PubMed ID: 22171261
[TBL] [Abstract][Full Text] [Related]
2. Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
Meisinger-Henschel C; Späth M; Lukassen S; Wolferstätter M; Kachelriess H; Baur K; Dirmeier U; Wagner M; Chaplin P; Suter M; Hausmann J
J Virol; 2010 Oct; 84(19):9907-19. PubMed ID: 20668072
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence.
Ember SWJ; Ren H; Ferguson BJ; Smith GL
J Gen Virol; 2012 Oct; 93(Pt 10):2098-2108. PubMed ID: 22791606
[TBL] [Abstract][Full Text] [Related]
4. The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.
Andrade AA; Silva PN; Pereira AC; De Sousa LP; Ferreira PC; Gazzinelli RT; Kroon EG; Ropert C; Bonjardim CA
Biochem J; 2004 Jul; 381(Pt 2):437-46. PubMed ID: 15025565
[TBL] [Abstract][Full Text] [Related]
5. A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication.
de Magalhães JC; Andrade AA; Silva PN; Sousa LP; Ropert C; Ferreira PC; Kroon EG; Gazzinelli RT; Bonjardim CA
J Biol Chem; 2001 Oct; 276(42):38353-60. PubMed ID: 11459835
[TBL] [Abstract][Full Text] [Related]
6. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
Peng C; Moss B
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3759-3767. PubMed ID: 32019881
[TBL] [Abstract][Full Text] [Related]
7. Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara.
Meisinger-Henschel C; Schmidt M; Lukassen S; Linke B; Krause L; Konietzny S; Goesmann A; Howley P; Chaplin P; Suter M; Hausmann J
J Gen Virol; 2007 Dec; 88(Pt 12):3249-3259. PubMed ID: 18024893
[TBL] [Abstract][Full Text] [Related]
8. Vaccinia virus F5 is required for normal plaque morphology in multiple cell lines but not replication in culture or virulence in mice.
Dobson BM; Procter DJ; Hollett NA; Flesch IE; Newsome TP; Tscharke DC
Virology; 2014 May; 456-457():145-56. PubMed ID: 24889234
[TBL] [Abstract][Full Text] [Related]
9. Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells.
Gedey R; Jin XL; Hinthong O; Shisler JL
J Virol; 2006 Sep; 80(17):8676-85. PubMed ID: 16912315
[TBL] [Abstract][Full Text] [Related]
10. Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha.
Backes S; Sperling KM; Zwilling J; Gasteiger G; Ludwig H; Kremmer E; Schwantes A; Staib C; Sutter G
J Gen Virol; 2010 Feb; 91(Pt 2):470-82. PubMed ID: 19846675
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-apoptotic protein F1L synergize to suppress cell death during infection.
Postigo A; Martin MC; Dodding MP; Way M
Cell Microbiol; 2009 Aug; 11(8):1208-18. PubMed ID: 19388902
[TBL] [Abstract][Full Text] [Related]
12. Vaccinia virus hijacks EGFR signalling to enhance virus spread through rapid and directed infected cell motility.
Beerli C; Yakimovich A; Kilcher S; Reynoso GV; Fläschner G; Müller DJ; Hickman HD; Mercer J
Nat Microbiol; 2019 Feb; 4(2):216-225. PubMed ID: 30420785
[TBL] [Abstract][Full Text] [Related]
13. The C11R gene, which encodes the vaccinia virus growth factor, is partially responsible for MVA-induced NF-κB and ERK2 activation.
Martin S; Harris DT; Shisler J
J Virol; 2012 Sep; 86(18):9629-39. PubMed ID: 22740414
[TBL] [Abstract][Full Text] [Related]
14. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses.
Antoine G; Scheiflinger F; Dorner F; Falkner FG
Virology; 1998 May; 244(2):365-96. PubMed ID: 9601507
[TBL] [Abstract][Full Text] [Related]
15. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of poxvirus orthologues of the vaccinia virus E3 protein: modulation of protein kinase R activity, cytokine responses, and virus pathogenicity.
Myskiw C; Arsenio J; Hammett C; van Bruggen R; Deschambault Y; Beausoleil N; Babiuk S; Cao J
J Virol; 2011 Dec; 85(23):12280-91. PubMed ID: 21917954
[TBL] [Abstract][Full Text] [Related]
17. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.
Meyer H; Sutter G; Mayr A
J Gen Virol; 1991 May; 72 ( Pt 5)():1031-8. PubMed ID: 2033387
[TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model.
Beard PM; Froggatt GC; Smith GL
J Gen Virol; 2006 Jun; 87(Pt 6):1521-1529. PubMed ID: 16690916
[TBL] [Abstract][Full Text] [Related]
19. Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virus.
Pollara JJ; Spesock AH; Pickup DJ; Laster SM; Petty IT
Virology; 2012 Jul; 428(2):146-55. PubMed ID: 22534090
[TBL] [Abstract][Full Text] [Related]
20. A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus.
Peters NE; Ferguson BJ; Mazzon M; Fahy AS; Krysztofinska E; Arribas-Bosacoma R; Pearl LH; Ren H; Smith GL
PLoS Pathog; 2013; 9(10):e1003649. PubMed ID: 24098118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
